Skip to main content
NCBI home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;24(9):592–596. doi: 10.1002/clc.4960240905

Safety and potential cost savings of same‐setting electrophysiologic testing and placement of transvenous implantable cardioverter‐defibrillators

Luis A Pires 1,✉, Lynette M May 1, Srihari Ravi 1, Vinit R Lal 1, Jaskamal P S Kahlon 1
PMCID: PMC6654776  PMID: 11558840

Abstract

Background: Separately, electrophysiologic study (EPS) and placement of a transvenous implantable cardioverter‐defibrillator (ICD) can be performed safely in the majority of patients. The safety and potential cost savings of same‐setting procedures have not been evaluated.

Hypothesis: Electrophysiologic study and placement of transvenous ICDs can be performed safely in the same setting at reduced cost.

Methods: in all, 160 (mean age 65 ± 10 years, 75% men) and 41 (mean age 66 ± 11 years, 73% men) consecutive patients who underwent same‐ versus separate‐setting procedures, respectively, were prospectively evaluated.

Results: The two groups had similar clinical characteristics and indications for EPS and ICD therapy. Complications occurred in eight patients (5.0%, 95% confidence interval [CI] 2.3–10.3) who had same‐setting procedures (one hypotension during ICD testing, one pocket hematoma, two lead dislodgments, two pneumothoraces, one stroke, and one infection) and in two (4.9%, CI 0.60–16.5) who had separate‐setting procedures (one pocket hematoma and one infection). There were no procedure‐related deaths or long‐term ICD‐related complications in either group. The mean time from ICD implantation to hospital discharge was similar in the two groups (2.5 ± 2.4 vs. 2.7 ± 2.2 days, p = NS). The combined procedure cost was higher in patients who had separate‐setting procedures ($12,403 ± 1,386 vs. $10,242 ± 2,256, p = < 0.001), who incurred an additional hospital cost of $2,121 ± $2,125 for the waiting period (1.7 ± 1.6 days) between EPS and ICD implantation.

Conclusions: in patients deemed candidates for ICD therapy based on EPS results, placement of transvenous defibrillators in the same setting as EPS is as safe as separate‐setting procedures and, if adopted, could further reduce the cost of providing ICD therapy.

Keywords: cost, electrophysiologic study, implantable cardioverter‐defibrillator

Full Text

The Full Text of this article is available as a PDF (484.0 KB).

References

  • 1. Cannom DS, Prystowsky EN: Management of ventricular arrhythmias: Detection, drugs, and devices. J Am Med Assoc 1999; 281: 172–179 [DOI] [PubMed] [Google Scholar]
  • 2. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators : A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near‐fatal sustained ventricular arrhythmias. N Engl J Med 1997; 337: 1576–1583 [DOI] [PubMed] [Google Scholar]
  • 3. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M: Improved survival with an implanted defibrillator in patients with coronary disease at risk for ventricular arrhythmias. A'? Engl J Med 1996; 335: 1933–1940 [DOI] [PubMed] [Google Scholar]
  • 4. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G: A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999; 341: 1882–1890 [DOI] [PubMed] [Google Scholar]
  • 5. Fitzpatrick AP, Lesh MD, Epstein LM, Lee RJ, Siu A, Merrick S, Griffin JC, Scheinman NM: Electrophysiological laboratory, electrophysiologist‐implanted, nonthoracotomy‐implantable cardioverter defibrillators. Circulation 1994; 89: 2503–2508 [DOI] [PubMed] [Google Scholar]
  • 6. Strickberger SA, Niebauer M, Man KC, Daoud E, Williamson BD, Horwood L, Hummel JD, Morady F: Comparison of implantation of nonthoracotomy defibrillators in the operating room versus the electrophysiology laboratory. Am J Cardiol 1995; 75: 255–257 [DOI] [PubMed] [Google Scholar]
  • 7. Tung RT, Bajaj AK: Safety of implantation of a cardioverter‐defibrillator without general anesthesia in an electrophysiology laboratory. Am J Cardiol 1995; 75: 908–912 [DOI] [PubMed] [Google Scholar]
  • 8. Manolis AS, Chiladakis J, Vassilikos V, Maounis T, Cokkinos DV: Pectoral cardioverter defibrillators: Comparison of prepectoral and submuscular implantation techniques. PACE 1999: 22: 469–478 [DOI] [PubMed] [Google Scholar]
  • 9. Pacifico A, Wheelan KR, Nasir N, Wells PJ, Doyle TK, Johnson SA, Henry PD: Long‐term follow‐up of cardioverter‐defibrillator implanted under conscious sedation in prepectoral subfascial position. Circulation 1997; 95: 946–950 [DOI] [PubMed] [Google Scholar]
  • 10. Singer I, Deam G, Payne V, Cicic A, Martin T: Clinical results with electrophysiologist‐implanted cardioverter‐defibrillators. PACE 1997; 20: 189–193 [DOI] [PubMed] [Google Scholar]
  • 11. van Rugge FP, Savalle LH, Schalij MJ: Subcutaneous single‐incision implantation of cardioverter‐defibrillators under local anesthesia by electrophysiologists in the electrophysiology laboratory. Am J Cardiol 1988; 81: 302–305 [DOI] [PubMed] [Google Scholar]
  • 12. Strickberger SA, Hummel JD, Daoud E, Niebauer M, Williamson BD, Man KC, Horwood L, Schmittou A, Kalbfleisch SJ, Langberg JJ, Morady F: Implantation by electrophysiologist of 100 consecutive cardioverter defibrillators with nonthoracotomy lead systems. Circulation 1994; 90: 868–872 [DOI] [PubMed] [Google Scholar]
  • 13. Dolack GL, Poole JE, Kudenchuk PJ, Raitt MH, Gleva MJ, Anderson J, Troutman C, Bardy GH: Management of ventricular fibrillation with transvenous defibrillators without baseline electrophysiologic testing or antiarrhythmic drugs. J Cardiovasc Electrophysiol 1996; 7: 197–202 [DOI] [PubMed] [Google Scholar]
  • 14. Link MS, Costeas XF, Griffith JL, Colburn CD, Estes NAM, Wang PJ: High incidence of appropriate implantable cardioverter‐defibrillator therapy in patients with syncope of unknown etiology and inducible ventricular arrhythmias. J Am Coll Cardiol 1997; 29: 370–375 [DOI] [PubMed] [Google Scholar]
  • 15. Williamson BD, Man KC, Niebauer MJ, Daoud EG, Strickberger SA, Hummel JD, Morady F: The economic impact of transvenous defibrillation lead systems. PACE 1994; 17: 2297–2303 [DOI] [PubMed] [Google Scholar]
  • 16. Venditti FJ O'Connell M, Martin DT, Shahian DM: Transvenous cardioverter defibrillators: Cost implications of a less invasive approach. PACE 1995; 18: 711–715 [DOI] [PubMed] [Google Scholar]
  • 17. Gold MR, Froman D, Kavesh NG, Peters RW, Foster AH, Shorofsky SR: A comparison of pectoral and abdominal transvenous defibrillator implantation: Analysis of costs and outcomes. J Intervent Electrophysiol 1998; 2: 345–349 [DOI] [PubMed] [Google Scholar]
  • 18. Anvari A, Stix G, Grabenwoger M, Schneider B, Turel Z, Schmidinger H: Comparison of three cardioverter defibrillator implantation techniques: Initial results with transvenous pectoral implantation. PACE 1996; 19: 1061–1069 [DOI] [PubMed] [Google Scholar]
  • 19. Bollmann A, Kanuru NK, DeLurgio D, Walter PF, Burnette JC, Langberg JJ: Comparison of three different automatic defibrillator implantation approaches: Pectoral implantation using conscious sedation reduces procedure times and cost. J Intervent Electrophysiol 1997; 1: 221–225 [DOI] [PubMed] [Google Scholar]
  • 20. Horowitz LN: Safety of electrophysiologic studies. Circulation 1986; 73: 11–28 [PubMed] [Google Scholar]
  • 21. Zipes DP, DiMarco JP, Gillette PC, Jackman WM, Myerberg RJ, Rahimtoola SH: ACC/AHA task force report: Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. J Am Coll Cardiol 1995; 26: 555–573 [DOI] [PubMed] [Google Scholar]
  • 22. Gregoratos G, Cheitlin MD, Conill A, Epstein AE, Fellows C, Ferguson TB, Freedman RA, Hlatky MA, Naccarelli GV, Saksena S, Schlant RC, Silka MJ: ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: A report of the ACC/AHA Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 1998; 31: 1175–1209 [DOI] [PubMed] [Google Scholar]
  • 23. Blanck Z, Deshpande S, Jazayeri SJ, Akhtar M: Bundle branch reentrant ventricular tachycardia: Cumulative experience in 48 patients. J Cardiov Electrophysiol 1993; 4: 253–262 [DOI] [PubMed] [Google Scholar]
  • 24. Gold MR, Peters RW, Johnson JW, Shorofsky SR: Complications associated with pectoral cardioverter‐defibrillator implantation: Comparison of subcutaneous and submuscular approaches. J Am Coll Cardiol 1996; 28: 1278–1282 [DOI] [PubMed] [Google Scholar]
  • 25. Rosenqvist M, Beyer T, Block M den Dulk K, Minten J, Lindemans F: Adverse events with transvenous implantable cardioverter‐defibrillators: A prospective multicenter study. Circulation 1998; 98: 663–670 [DOI] [PubMed] [Google Scholar]
  • 26. Wever EFD, Hauer RNW, Schrijvers G van Capelle FJL, Tijssen JGP, Crijns HJGM, Algra A, Ramanna H, Bakker PFA de Medina EOR: Cost‐effectiveness of implantable defibrillator as first‐choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors: A randomized study. Circulation 1996; 93: 489–496 [DOI] [PubMed] [Google Scholar]
  • 27. Mushlin AI, Hall WJ, Zwanziger J, Gajary E, Andrews M, Marron R, Zou KH, Moss AJ: The cost‐effectiveness of automatic implantable cardiac defibrillators: Results form MADIT. Circulation 1998; 97: 2129–2135 [DOI] [PubMed] [Google Scholar]
  • 28. Zipes DP, Roberts D, for the PCD Investigators : Results of the international study of the implantable pacemaker cardioverter defibrillator: A comparison of epicardial and endocardial lead systems. Circulation 1995; 92: 59–65 [DOI] [PubMed] [Google Scholar]
  • 29. Knight BP, Goyal R, Pelosi F, Flemming M, Horwood L, Morady F, Strickberger SA: Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol 1999; 33: 1964–1970 [DOI] [PubMed] [Google Scholar]
  • 30. Andrews NP, Fogel RI, Pelargonio G, Evans JJ, Prystowsky EN: Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias; A comparison with patients known to have sustained ventricular tachycardia. J Am Coll Cardiol 1999; 34: 2023–2030 [DOI] [PubMed] [Google Scholar]
  • 31. Pires LA, May LM, Ravi SR, Parry JT, Lai VR, Nino CL: Comparison of event rates and survival in patients with unexplained syncope without documented ventricular tachyarrhythmias versus patients with documented sustained ventricular tachyarrhythmias both treated with implantable cardioverter‐defibrillators. Am J Cardiol 2000; 85: 725–728 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES